abstract |
The present invention relates to neurodegenerative diseases, brain and spinal injury, age-related learning and memory problems of peptides consisting of 5-30 amino acid residues, preferably 9-15, most preferably about 12 amino acid residues and For use for the manufacture of a medicament for the modulation of NCAM function administered for the prevention and / or treatment of cancer, said peptide is recognized by anti-poly-α2,8 sialic acid (PSA) antibody NCAM Contains the B epitope of poly-α2,8 sialic acid bound to |